- Home
- PAII vs QSI Comparison
PAII vs QSI Comparison
Compare PAII & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAII | QSI |
|---|---|---|
| Founded | 2025 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.8M | 273.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PAII | QSI |
|---|---|---|
| Price | $10.13 | $0.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 54.2K | ★ 3.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $196.35 |
| Revenue Next Year | N/A | $229.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.92 | $0.84 |
| 52 Week High | $10.17 | $3.10 |
Technical Indicators
Market Signals| Indicator | PAII | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.42 | 36.50 |
| Support Level | $10.04 | N/A |
| Resistance Level | N/A | $1.33 |
| Average True Range (ATR) | 0.03 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 75.00 | 16.67 |
Price Performance
Historical ComparisonAbout PAII Pyrophyte Acquisition Corp. II Class A Ordinary Shares
Pyrophyte Acquisition Corp II is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.